Francesco Pignatti, MD

European Medicines Agency, Netherlands

Disclosure information not submitted.

Presentation(s):

• The nature of uncertainties on the benefit-risk balance of anticancer medicines at initial marketing authorisation in the European Union

  Monday, August 26, 2024
  2:30 PM – 2:45 PM CEST